Metastatic Colorectal Cancer, Age Groups, Epidemiology, Screening, National Inpatient Sample, Temporal Trend Gill, J. , Brady, H. and Mbachi, C. (2026) The Rising Trend Hospital-Based Study across Age ...
Controlled study designed to confirm previous compelling efficacy with preliminary data expected by the end of 2026Pelareorep-based treatment ...
mCRC treatment involves balancing efficacy, tolerability, and patient goals, with fruquintinib, regorafenib, and trifluridine-tipiracil as key therapies. Oncology pharmacists are essential in ...
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to ...
SAN FRANCISCO -- Adding modified FOLFOX6 (oxaliplatin, leucovorin, and fluorouracil) and bevacizumab (Avastin) to atezolizumab (Tecentriq) significantly improved progression-free survival (PFS) in ...
David Lyon, now 31, was diagnosed with stage 4 colon cancer at 26. For March's Colorectal Cancer Awareness Month, he's urging ...
Colorectal cancer has become the leading cause of cancer death in people under the age of 50. Early studies suggest that increased alcohol consumption, ultra-processed foods, and obesity may be ...
A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.
Cancer survivors visit the Fight Colorectal Cancer "United in Blue" flag installation on the National Mall to spotlight the ...
Creatv Bio has demonstrated that monitoring the expressions of PD-L1 using the LifeTracDx ® blood test at baseline, followed by sequential sampling after induction of therapy, may identify patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results